Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

February 6, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

February 29, 2020

Conditions
Opioid Use
Interventions
BEHAVIORAL

Training

The training includes of (1) in-person training with pre- and post-session knowledge and attitude assessment, (2) three month post-session knowledge and attitude assessment and (3) self-report of first-time buprenorphine-naloxone Emergency Department (ED) administration within 3 month study period

BEHAVIORAL

Behavioral economic enhanced arm

Behavioral economic enhancement includes an opt-out invitation, loss-framed incentivization, weekly tailored text based reminders

Trial Locations (1)

19104

University of Pennsylvania Health System, Philadelphia

All Listed Sponsors
collaborator

American College of Medical Toxicology

OTHER

collaborator

Blue Cross Blue Shield

OTHER

lead

University of Pennsylvania

OTHER

NCT03821103 - Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments | Biotech Hunter | Biotech Hunter